P T Lukey

Author PubWeight™ 18.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Baseline sputum time to detection predicts month two culture conversion and relapse in non-HIV-infected patients. Int J Tuberc Lung Dis 2010 2.00
2 Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A. J Immunol 2000 1.58
3 Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy. Clin Exp Immunol 2006 1.21
4 In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculous granulomas. Infect Immun 2000 1.19
5 Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer T cells in fast treatment responders. Clin Exp Immunol 2006 1.09
6 Evidence for in vivo generation of cytotoxic T cells. PPD-stimulated lymphocytes from tuberculous pleural effusions demonstrate enhanced cytotoxicity with accelerated kinetics of induction. Am Rev Respir Dis 1992 1.07
7 An in-vitro comparison of the intraphagocytic bioactivity of erythromycin and roxithromycin. J Antimicrob Chemother 1987 1.03
8 HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosis. J Infect Dis 2001 1.01
9 Reduced NK activity correlates with active disease in HIV- patients with multidrug-resistant pulmonary tuberculosis. Clin Exp Immunol 1994 0.99
10 The human macrophage cell line U937 as an in vitro model for selective evaluation of mycobacterial antigen-specific cytotoxic T-cell function. Immunology 2001 0.97
11 Monocyte-derived macrophage cytokine responses induced by M. bovis BCG. Tuber Lung Dis 2000 0.91
12 Dithranol mediates pro-oxidative inhibition of polymorphonuclear leukocyte migration and lymphocyte proliferation. Br J Dermatol 1987 0.80
13 Reduced natural killer cell activity in multi-drug resistant pulmonary tuberculosis. Scand J Immunol Suppl 1992 0.80
14 Granule-dependent cytolysis of Mycobacterium tuberculosis-infected macrophages by human gammadelta+ T cells has no effect on intracellular mycobacterial viability. Clin Exp Immunol 2001 0.80
15 Benoxaprofen: a pro-oxidant anti-inflammatory drug? Agents Actions 1984 0.78
16 A biological role for ascorbate in the selective neutralization of extracellular phagocyte-derived oxidants. Ann N Y Acad Sci 1987 0.77
17 Defective polymorphonuclear leukocyte migration in AIDS. S Afr Med J 1985 0.77
18 Basic fibroblast growth factor antagonizes transforming growth factor beta-mediated erythroid differentiation in K562 cells. Blood 1994 0.76
19 Ascorbate and cysteine-mediated selective neutralisation of extracellular oxidants during N-formyl peptide activation of human phagocytes. Agents Actions 1987 0.75
20 Effects of benoxaprofen on the binding to and inactivation of leucoattractants by human polymorphonuclear leucocytes in vitro. Agents Actions 1985 0.75
21 Polymorphonuclear leucocyte function, juvenile periodontitis and bacterial infections. S Afr Med J 1985 0.75
22 Prostanoid modulation of synovial antigen-specific CD4+ T-cell cytotoxic function in rheumatoid arthritis. Br J Rheumatol 1995 0.75